Page last updated: 2024-09-05

lixivaptan and aldosterone

lixivaptan has been researched along with aldosterone in 1 studies

Compound Research Comparison

Studies (lixivaptan)	Trials (lixivaptan)	Recent Studies (post-2010) (lixivaptan)	Studies (aldosterone)	Trials (aldosterone)	Recent Studies (post-2010) (aldosterone)
80	10	26	25,333	1,517	4,169

Protein Interaction Comparison

Protein	Taxonomy	lixivaptan (IC50)	aldosterone (IC50)
Mineralocorticoid receptor	Homo sapiens (human)		0.0048
Mineralocorticoid receptor	Rattus norvegicus (Norway rat)		0.043

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blei, AT; Blendis, LM; Thuluvath, PJ; Wong, F	1

Trials

1 trial(s) available for lixivaptan and aldosterone

Article	Year
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:1 Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyrroles; Renin; Sodium; Thirst; Treatment Outcome; Water-Electrolyte Balance	2003

Article

Year

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:1

Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyrroles; Renin; Sodium; Thirst; Treatment Outcome; Water-Electrolyte Balance

2003